CNBC: FDA approves second Covid vaccine for emergency use as it clears Moderna's for U.S. distribution
The Food and Drug Administration has approved Moderna's coronavirusvaccine for emergency use. The vaccine — the second approved for use in the U.S. behind Pfizer and BioNTech's — bolsters the U.S. supply of doses. The potentially lifesaving shots are desperately needed to fend off the pandemic that has taken more than 300,000 American lives and overwhelmed hospitals.
The FDA's emergency use authorization approves the federal government's plan to distribute roughly 5.9 million doses of Moderna's vaccine to 64 states, territories and major cities across the nation next week.
"We likely will see shots in the arm by the very early part of next week, I would hope Monday or Tuesday," Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, said on the "Today" show on Friday morning.
In addition to Moderna's vaccine, the U.S. also plans to send out 2 million doses of Pfizer's vaccine after 2.9 million doses were cleared for shipment this week, Gen. Gustave Perna, who oversees logistics for the Operation Warp Speed vaccine project, said Monday. Both vaccines require two doses three to four weeks apart. Moderna's Covid vaccine is its first-ever FDA authorized product.
U.S. officials hope to vaccinate at least 20 million Americans — mostly front-line health-care workers and nursing home residents — by the end of the year. Initial doses will be limited as manufacturing ramps up, with officials predicting it will take months to immunize everyone in the U.S. who wants to be vaccinated. The Centers for Disease Control and Prevention has provided states with an outline that recommends prioritizing health workers and nursing homes, but states can distribute the vaccine as they see fit.